Monday, February 26, 2024
GenEndeavor is a molecular diagnostics technology company on a mission to prevent genetic and infectious diseases by quickly and accurately detecting pathological biomarkers in early stages.
CEO/Top Company Official
Lead Product in Development
Point of care, non-invasive early ovarian cancer monitoring test for existing patients and asymptomatic high-risk women
Development Phase of Primary Product
Number Of Unlicensed Products